RGRX.OB Insider Trading Activity and SEC Form 4 Filings
RGRX.OB insider trading summary
No open-market insider purchases or sales of Regenerx Biopharmaceuticals Inc (RGRX.OB) have been reported on SEC Form 4 in the past 12 months.
Latest RGRX.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 5, 2011 | Tau Finanziaria Spa Sigma | 10% Owner | Buy | $250K (925,926 @ $0.27) |
| Jan 5, 2011 | Farmaceutica Lda Defiante | 10% Owner | Buy | $250K (925,926 @ $0.27) |
| Jan 5, 2011 | Paolo Cavazza | 10% Owner | Buy | $250K (925,926 @ $0.27) |
| Jan 5, 2011 | Paolo Cavazza | 10% Owner | Buy | $350K (1,296,297 @ $0.27) |
| Jan 5, 2011 | Claudio Cavazza | 10% Owner | Buy | $350K (1,296,296 @ $0.27) |
| Jan 5, 2011 | Claudio Cavazza | 10% Owner | Buy | $250K (925,926 @ $0.27) |
| Jan 5, 2011 | S.A. Sinaf | 10% Owner | Buy | $350K (1,296,297 @ $0.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.